Literature DB >> 19020295

Premutation allele pool in myotonic dystrophy type 2.

L L Bachinski1, T Czernuszewicz, L S Ramagli, T Suominen, M D Shriver, B Udd, M J Siciliano, R Krahe.   

Abstract

BACKGROUND: The myotonic dystrophies (DM1, DM2) are the most common adult muscle diseases and are characterized by multisystem involvement. DM1 has been described in diverse populations, whereas DM2 seems to occur primarily in European Caucasians. Both are caused by the expression of expanded microsatellite repeats. In DM1, there is a reservoir of premutation alleles; however, there have been no reported premutation alleles for DM2. The (CCTG)(DM2) expansion is part of a complex polymorphic repeat tract of the form (TG)(n)(TCTG)(n)(CCTG)(n)(NCTG)(n)(CCTG)(n). Expansions are as large as 40 kb, with the expanded (CCTG)(n) motif uninterrupted. Reported normal alleles have up to (CCTG)(26) with one or more interruptions.
METHODS: To identify and characterize potential DM2 premutation alleles, we cloned and sequenced 43 alleles from 23 individuals. Uninterrupted alleles were identified, and their instability was confirmed by small-pool PCR. We determined the genotype of a nearby single nucleotide polymorphism (rs1871922) known to be in linkage disequilibrium with the DM2 mutation.
RESULTS: We identified three classes of large non-DM2 repeat alleles: 1) up to (CCTG)(24) with two interruptions, 2) up to (CCTG)(32) with up to four interruptions, and 3) uninterrupted (CCTG)(22-33). Large non-DM2 alleles were more common in African Americans than in European Caucasians. Uninterrupted alleles were significantly more unstable than interrupted alleles (p = 10(-4) to 10(-7)). Genotypes at rs1871922 were consistent with the hypothesis that all large alleles occur on the same haplotype as the DM2 expansion.
CONCLUSIONS: We conclude that unstable uninterrupted (CCTG)(22-33) alleles represent a premutation allele pool for DM2 full mutations.

Entities:  

Mesh:

Year:  2008        PMID: 19020295      PMCID: PMC2677510          DOI: 10.1212/01.wnl.0000333665.01888.33

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands.

Authors:  B Udd; G Meola; R Krahe; C Thornton; L Ranum; J Day; G Bassez; K Ricker
Journal:  Neuromuscul Disord       Date:  2003-09       Impact factor: 4.296

2.  Stabilizing effects of interruptions on trinucleotide repeat expansions in Saccharomyces cerevisiae.

Authors:  M L Rolfsmeier; R S Lahue
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Ethnic distribution of myotonic dystrophy gene.

Authors:  T Ashizawa; H F Epstein
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

4.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

5.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

6.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

7.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

8.  Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.

Authors:  Christina L Liquori; Yoshio Ikeda; Marcy Weatherspoon; Kenneth Ricker; Benedikt G H Schoser; Joline C Dalton; John W Day; Laura P W Ranum
Journal:  Am J Hum Genet       Date:  2003-09-22       Impact factor: 11.025

9.  Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR.

Authors:  Mary Coolbaugh-Murphy; Atousa Maleki; Lou Ramagli; Marsha Frazier; Benjamin Lichtiger; Darren G Monckton; Michael J Siciliano; Barry W Brown
Journal:  Genomics       Date:  2004-08       Impact factor: 5.736

10.  Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families.

Authors:  Tsukasa Saito; Yoshinobu Amakusa; Takashi Kimura; Osamu Yahara; Hitoshi Aizawa; Yoshio Ikeda; John W Day; Laura P W Ranum; Kinji Ohno; Tohru Matsuura
Journal:  Neurogenetics       Date:  2007-12-05       Impact factor: 2.660

View more
  24 in total

1.  Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.

Authors:  Olayinka Raheem; Shodimu-Emmanuel Olufemi; Linda L Bachinski; Anna Vihola; Mario Sirito; Jeanette Holmlund-Hampf; Hannu Haapasalo; Yi-Ping Li; Bjarne Udd; Ralf Krahe
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

2.  Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay.

Authors:  Eran Bram; Kamyab Javanmardi; Kimberly Nicholson; Kristen Culp; Julie R Thibert; Jon Kemppainen; Vivian Le; Annette Schlageter; Andrew Hadd; Gary J Latham
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-11-15       Impact factor: 4.092

Review 3.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 4.  Myotonic dystrophy.

Authors:  Charles A Thornton
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

Review 5.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

6.  Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.

Authors:  Mark Screen; Per Harald Jonson; Olayinka Raheem; Johanna Palmio; Reijo Laaksonen; Terho Lehtimäki; Mario Sirito; Ralf Krahe; Peter Hackman; Bjarne Udd
Journal:  Am J Pathol       Date:  2014-06-05       Impact factor: 4.307

7.  If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  James E Hilbert; John T Kissel; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Donald B Sanders; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Contemp Clin Trials       Date:  2011-11-26       Impact factor: 2.226

Review 8.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

9.  A Z-DNA sequence reduces slipped-strand structure formation in the myotonic dystrophy type 2 (CCTG) x (CAGG) repeat.

Authors:  Sharon F Edwards; Mario Sirito; Ralf Krahe; Richard R Sinden
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

10.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.